Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

1,200 public trials 264 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Completed

UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch

NCT02643043

Conditions
Bladder Cancer, Cancer of the Ureter, Carcinoma, +20 more
Locations
  • University of Southern Cailfornia Los Angeles, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Ichan School of Medicine at Mount Sinai New York, United States
View Trial Details
Completed

Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer

NCT02722538

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Columbia University Medical Center New York, United States
View Trial Details
Completed

A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer

NCT02426125

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +15 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • St. Jude Medical Center Fullerton, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
View all 141 locations
View Trial Details
Completed

Ask Questions (ASQ):Implementation of a Communication Intervention

NCT05025748

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +68 more
Locations
  • Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States
  • Karmanos Cancer Institute at McLaren Clarkston Clarkston, Michigan, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States
View Trial Details
Completed

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

NCT03636256

Conditions
Bladder Cancer, Cancer of the Bladder, Carcinoma, +20 more
Locations
  • BCG Oncology, PC Phoenix, Arizona, United States
  • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, Maryland, United States
  • Columbia University Herbert Irving Comprehensive Cancer Center New York, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details

Related conditions